维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="Spruance SL"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Treatment of genital warts with an immune-response modifier (imiquimod) 显示文摘	Beutner KR Spruance SL Hougham AJ	1998	J Am Acad Dermatol1998，38，21：	1
2	Treatment of genital warts with an immune - response modifier (imiquimod) 显示文摘	Beutner KR Spruance SL Hougham AJ	1998	J Am Acad Dermatol1998，38，21：	1
3	Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease 显示文摘	Spruance SL Daynes RA	1996	J Inf Dis1996，173，：	1
4	Treatment of genital war ts with an immune response modifier(imiquimod)显示文摘	BEUTNER KR SPRUANCE SL HOUGHAM AJ	1998	J Am Acad Dermatol1998，38，21：	1
5	Immunostimulatory function of herpes simplex virus isolates from patients with frequent herpes labialis and a deficiency in immune-specific interferon production显示文摘	Klieman RL Green JA Spruance SL	1985	J Med Virol1985，16，3：	1
6	Hazard ratio in clinical trials显示文摘	Spruance SL Reid JE Grace M	2004	Antimicrob Agents Chemother2004，48，8：	1
7	Glycoprotein D adjuvant vaccine to prevent genital hcrpes 显示文摘	Stanbery LR Spruance SL Cunningham AL	2002	N Engl Med2002，347，：	1
8	Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study显示文摘	Spruance SL Tyring SK Smith MH	2001	J Infect Dis2001，184，2：	1
9	Transcranial Doppler quantifica- tion of residual shunt after percutaneous patent foramen ovale closure : correla- tion of device efficacy with intracardiac anatomic measures 显示文摘	Sorensen SG Spruance SL Smout R	2012	J Interv Cardi- ol2012，25，3：	1
10	Glycoprotein-D- adjuvant vaccine to prevent genital herpes 显示文摘	Stanberry LR Spruance SL Cunningham AL	2002	N Engl Med2002，347，21：	1
11	Treatment of genital warts with an immune-response modifier(imiquimod)显示文摘	Beutner KR Spruance SL Hougham A J	1998	J Am Acad Dermatol1998，38，：	1
12	Clinical and virologic course of herpes simplex genitalis显示文摘	Brown ZA Kern ER Spruance SL	1979	West J Med1979，130，5：	1
13	Treatment of genital wartswith an immune - response modifier (imiquimod) 显示文摘	Beutner KR Spruance SL Hougham AJ	1998	J Am Acad Dermatol1998，38，21：	1
14	Treat- ment of genital warts with an immune-response modifier (imiquimod)显示文摘	BEUTNER KR SPRUANCE SL HOUGHAM AJ	1998	J Am Acad Dermatol1998，38，21：	1
15	Treament of genital warts with an immune-response modifier (imiquimod)显示文摘	13eutner KR Spruance SL Hougham AJ	1998	J Am Acad Dermatol1998，38，2：	1
16	Hazard ratio in clinical tri- als显示文摘	Spruance SL Reild JE Grace M	2004	Antimicrob Agents Chemother2004，48，8：	1
17	Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease 显示文摘	Kriesel JD Spruance SL Daynes RA	1996	J Infect Dis1996，173，3：	1
18	Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure : correlation of device efficacy with intracardiac anatom- ic measures显示文摘	Sorensen SG Spruance SL Smout R	2012	J Interv Cardiol2012，25，3：	1
19	Hazard ratio in clinical trials显示文摘	SL Spruance Reid JE Grace M	2004	Antimicrobial agents and chemotherapy2004，48，8：	1
20	Treatment of genital warts with an immune-response modifier(imiquimod)显示文摘	Beutner KR Spruance SL Hougham AJ	1998	J Am Acad Dermatol1998，38，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示